Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.
An update on Mmr
Primary tabs
Autori:
Sezioni:
Indice:
Vaccination
prossimo articolo
The woman who built evidence-based policy making in Europe
Anne Glover is a Scottish professor of Molecular and Cell Biology and is ceasing her position as the first EU Chief Scientific Advisor (CSA) during the Barroso Commission II. She made a huge job in spreading the evidence-based method into policy making, by advising President Barroso with the most up-to-date scientific discoveries. But her second main goal was to create a network of all the people involved in